Insider Selling: Palomar (NASDAQ:PLMR) CEO Sells $613,000.00 in Stock

February 14, 2026 by InsiderTrades.com

Key Points

Palomar CEO Mac Armstrong sold 5,000 shares on Feb. 12 at about $122.60 for $613,000, trimming his stake by roughly 1.44% to 343,388 shares; the sale was disclosed in an SEC filing.
Strong Q4 results and positive analyst tone: Palomar beat Q4 estimates (EPS $2.24 vs. $2.06) with revenue up 62.7% year-over-year, management raised its 2026 outlook, the stock rose ~4%, and analysts maintain a "Moderate Buy" consensus with price targets around $150–$171.

Palomar Holdings, Inc. (NASDAQ:PLMR - Get Free Report) CEO Mac Armstrong sold 5,000 shares of the firm's stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $122.60, for a total transaction of $613,000.00. Following the transaction, the chief executive officer directly owned 343,388 shares in the company, valued at $42,099,368.80. The trade was a 1.44% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Down Over 80%, is Pet Insurer Trupanion Worth the Risk Premium?

Mac Armstrong also recently made the following trade(s):

On Saturday, January 31st, Mac Armstrong sold 2,205 shares of Palomar stock. The shares were sold at an average price of $121.74, for a total value of $268,436.70.
On Saturday, January 31st, Mac Armstrong sold 2,205 shares of Palomar stock. The stock was sold at an average price of $121.74, for a total value of $268,436.70.
On Thursday, January 29th, Mac Armstrong sold 5,399 shares of Palomar stock. The stock was sold at an average price of $122.04, for a total transaction of $658,893.96.
On Thursday, January 29th, Mac Armstrong sold 5,399 shares of Palomar stock. The stock was sold at an average price of $122.04, for a total transaction of $658,893.96.
On Wednesday, January 28th, Mac Armstrong sold 11,484 shares of Palomar stock. The stock was sold at an average price of $119.88, for a total value of $1,376,701.92.
On Wednesday, January 21st, Mac Armstrong sold 5,000 shares of Palomar stock. The shares were sold at an average price of $129.00, for a total value of $645,000.00.
On Thursday, January 15th, Mac Armstrong sold 2,310 shares of Palomar stock. The stock was sold at an average price of $130.00, for a total transaction of $300,300.00.
On Friday, November 21st, Mac Armstrong sold 5,000 shares of Palomar stock. The shares were sold at an average price of $122.86, for a total transaction of $614,300.00.

Palomar Stock Up 4.0%

Shares of NASDAQ PLMR opened at $132.10 on Friday. The stock has a market capitalization of $3.50 billion, a price-to-earnings ratio of 18.40 and a beta of 0.44. Palomar Holdings, Inc. has a 52 week low of $107.75 and a 52 week high of $175.85. The firm has a 50-day moving average price of $128.74 and a 200 day moving average price of $123.24.

3 Small Cap Stocks That May Someday be Large Caps

Palomar (NASDAQ:PLMR - Get Free Report) last issued its earnings results on Wednesday, February 11th. The company reported $2.24 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.06 by $0.18. The company had revenue of $492.63 million during the quarter, compared to analysts' expectations of $204.58 million. Palomar had a net margin of 22.50% and a return on equity of 22.77%. The firm's quarterly revenue was up 62.7% compared to the same quarter last year. During the same period last year, the company posted $1.52 earnings per share. Equities research analysts expect that Palomar Holdings, Inc. will post 5.99 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. Keefe, Bruyette & Woods raised their price target on Palomar from $170.00 to $171.00 and gave the company an "outperform" rating in a research report on Tuesday, January 6th. JPMorgan Chase & Co. raised their target price on shares of Palomar from $145.00 to $155.00 and gave the company an "overweight" rating in a report on Wednesday, January 7th. Evercore ISI began coverage on shares of Palomar in a report on Monday, February 9th. They issued an "outperform" rating and a $150.00 price target on the stock. Weiss Ratings raised shares of Palomar from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Wednesday, January 14th. Finally, Wall Street Zen lowered Palomar from a "buy" rating to a "hold" rating in a research note on Saturday, February 7th. Seven research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $158.14.

View Our Latest Research Report on PLMR

Key Palomar News

Here are the key news stories impacting Palomar this week:

Positive Sentiment: Q4 earnings and revenue beat consensus, driven by higher premiums and underwriting gains; management also raised its 2026 outlook — a primary driver of the stock’s strength. Palomar Q4 Earnings & Revenues Beat Estimates, Premiums Rise Y/Y
Positive Sentiment: Brokerage coverage remains constructive — the consensus recommendation is around “Moderate Buy,” which supports continued investor interest. Palomar Given Average Recommendation of "Moderate Buy" by Brokerages
Neutral Sentiment: Analyst/press deep-dive notes that Palomar’s diversification is driving top-line growth, but highlights emerging questions about margins and underwriting mix — watch margin trends in upcoming quarters. PLMR Q4 deep dive: Diversification drives growth, margin questions emerge
Neutral Sentiment: Full Q4 earnings call transcript is available for detail on management’s commentary and guidance assumptions — useful for investors modeling forward earnings and loss ratios. Palomar Q4 2025 Earnings Call Transcript
Negative Sentiment: Insider sale: CEO Mac Armstrong sold 5,000 shares at ~$122.60 (filed with the SEC), trimming his stake by ~1.44% — a potential sentiment headwind even though his remaining holding remains large. SEC Filing: Insider Sale

Hedge Funds Weigh In On Palomar

Institutional investors have recently modified their holdings of the company. Salomon & Ludwin LLC acquired a new stake in Palomar during the third quarter worth approximately $25,000. Richardson Financial Services Inc. raised its holdings in Palomar by 210.0% in the 3rd quarter. Richardson Financial Services Inc. now owns 217 shares of the company's stock valued at $25,000 after acquiring an additional 147 shares during the last quarter. Allworth Financial LP lifted its stake in shares of Palomar by 1,970.0% during the 2nd quarter. Allworth Financial LP now owns 207 shares of the company's stock worth $32,000 after purchasing an additional 197 shares during the period. Geneos Wealth Management Inc. acquired a new stake in shares of Palomar during the fourth quarter worth $32,000. Finally, Kestra Advisory Services LLC purchased a new stake in shares of Palomar in the fourth quarter valued at $33,000. Institutional investors and hedge funds own 90.25% of the company's stock.

Palomar Company Profile

(Get Free Report)

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.